CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations

American Journal of Pathology

Volumn 153, Issue 1, 1998, Pages 159-163

  Nielsen, Gunnlaugur P ^a   Burns, Karen L ^a,b   Rosenberg, Andrew E ^a   Louis, David N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P16;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CYCLE; CLINICAL ARTICLE; FEMALE; GENE ACTIVATION; GENE DELETION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

EID: 0031868951     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65556-3     Document Type: Article

References (30)

1. Szymanska J, Mandahl N, Mertens F, Tarkkanen M, Karaharju E, Knuutila S: Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: a combined cytogenetic and comparative genomic hybridization study. Genes Chromosomes Cancer 1996, 16:31-34
2. Yamaguchi T, Toguchida J, Yamamuro T, Kotoura Y, Takada N, Kawaguchi N, Kaneko Y, Nakamura Y, Sasaki MS, Ishizaki K: Allelo-type analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p and 18q. Cancer Res 1992, 52:2419-2423
3. Scheffer H, Kruize YCM, Osinga J, Kuiken G, Oosterhuis JW, Leeuw JA, Koops HS, Buys CHCM: Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcoma. Cancer Genet Cytogenet 1991, 53:45-55
4. Biegel JA, Womer RB, Emanuel BS: Complex karyotypes in a series of pediatric osteosarcomas. Cancer Genet Cytogenet 1989, 38:89-100
5. Toguchida J, Ishizaki K, Sasaki MS, Ikenaga M, Sugimoto M, Kotoura Y, Yamamuro T: Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 1988, 48:3939-3943
6. Horstmann MA, Pöst M, Scholz RB, Anderegg B, Simon P, Baumgaertl K, Delling G, Kabisch H: Frequent reduction or loss of DCC gene expression in human osteosarcoma. Br J Cancer 1997, 75: 1309-1317
7. Mertens F, Mandahl N, Örndal C, Baldetorp B, Bauer HCF, Rydholm A, Wiebe T, Willen H, Åkerman M, Heim S, Mitelman F: Cytogentic findings in 33 osteosarcomas. Int J Cancer 1993, 55:44-50
8. Kruzelock RP, Murphy EC, Strong LC, Naylor SL, Hansen MF: Localizations of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis. Cancer Res 1997, 57:106-109
9. Hoogerwerf WA, Hawkins AL, Perlman EJ, Griffin CA: Chromosome analysis of nine osteosarcomas. Genes Chromosomes Cancer 1994, 9:88-92
10. Draper GJ, Sanders BM, Kingston JE: Second primary neoplasms in patients with retinoblastoma. Br J Cancer 1986, 53:661-671
11. Araki N, Uchida A, Kimura T, Yoshikawa H, Aoki Y, Ueda T, Takai SI, Miki T, Ono K: Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors. Clin Orthop 1991, 270:271-277
12. Hansen MF, Koufos A, Gallie BL, Phillips RA, Fodstad Ø, Brøgger A, Gedde-Dahl T, Cavenee WK: Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 1985, 82:6216-6220
13. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y, Yamamuro T: Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 1994, 54:3042-3048
14. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986, 323: 643-646
15. Wunder JS, Czitrom AA, Kandel R, Andrulis IL: Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst 1991, 83:194-200
16. ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 1995, 92:6289-6293
17. INK4A transcript. Cancer Res 1995, 55:2995-2997
18. 1 control. Cancer Res 1995, 55:4818-4823
19. Ink4. Cancer Res 1994, 54:5816-5820
20. Wiman KG: The retinoblastoma gene: role in cell cycle control and cell differentiation. FASEB J 1993, 7:841-845
21. Li Y, Nichols MA, Shay JW, Xiong Y: Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994, 54:6078-6082
22. Cordon-Cardo C: Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 1995, 147:545-560
23. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN: CDKN2/p16 or RB alterations occur in the majority of glioblastomas, and are inversely correlated. Cancer Res 1996, 56:150-153
24. Louis DN, Rubio MP, Correa K, Gusella JF, von Deimling A: Molecular genetics of pediatric brain stem gliomas: application of PCR techniques to small and archival brain tumor specimens. J Neuropathol Exp Neurol 1993, 52:507-515
25. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, Benedict WF, Yandell DW, Louis DN: The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994, 36:714-721
26. Burns KL, Ueki K, Jhung SL, Koh J, Louis DN: Molecular genetics correlates of p16, cdk4 and pRb immunohistochemistry in glioblastomas. J Neuropathol Exp Neurol 1998, 57:122-130
27. Patino-García A, Sierrasesúmaga L: Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients. Cancer Genet Cytogenet 1997, 98:50-55
28. Maelandsmo GM, Berner JM, Flørenes VA, Forus A, Hovig E, Fodstad Ø, Myklebost O: Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas: relationship to amplification and mRNA levels of CDK4 and CCND1. Br J Cancer 1995, 72:393-398
29. Miller CW, Aslo A, Campbell MJ, Kawamata N, Lampkin BC, Koeffler HP: Alterations of the p15, p16, and p18 genes in osteosarcoma. Cancer Genet Cytogenet 1996, 86:136-142
30. Feugeas O, Guriec N, Babin-Boilletot A, Marcellin L, Simon P, Babin S, Thyss A, Hofman P, Terrier P, Kalifa C, Brunat-Mentigny M, Patricot LM, Oberling F: Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcorna. J Clin Oncol 1996, 14:467-472